Kids v Cancer is excited to announce that on February 14th, Valentines Day, the FDA awarded the first Creating Hope Act voucher! The voucher was awarded to BioMarin for Vimizim to treat Morquio A Syndrome.
The voucher will provide a monetary incentive to BioMarin to make it possible for BioMarin to develop drugs for kids with rare and serious illnesses, like Annabelle.
There are fewer than 800 kids in the United States with Morquio A Syndrome. Vimizim will help Annabelle live a longer and healthier life. That's what every kid should have.
We would like to thank BioMarin for helping kids like Annabelle, the FDA for implementing the Creating Hope Act, Annabelle for being a great kid, and you — without you, this would not have been possible.
Learn more about Vimizim and Annabelle's journey.